FindTrial
Sign In

Continuous Glucose Monitoring in menstruating women with Type 2 Diabetes

Glucose Control in Women with Type 2 Diabetes Assessed by Continuous Glucose Monitoring ââ?¬â?? The Effect of the Menstrual Cycle : An Observational Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/10/046121
Enrollment
25
Registered
2022-10-03
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

Smitha Bhat
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Women with Type 2 diabetes as per ADA criteria , between the ages of 20 and 45 , with regular ( ovulatory) menstrual cycles

Exclusion criteria

Exclusion criteria: a. Women with irregular menstrual cycles b. Women taking hormonal contraception c. Pregnancy d. Breast feeding mothers e. Thyroid function abnormality f. Untreated or inadequately treated hypothyroidism. g. HbA1C > 8 h. eGFR i. Prednisone use for more than 10 days during the study

Design outcomes

Primary

MeasureTime frame
a. Primary outcome measures ââ?¬â?? estimate of glycemic variability in women in different phases of menstrual cycle Timepoint: at end of trial—

Secondary

MeasureTime frame
Secondary outcome measures ââ?¬â?? association of glycemic variability with parameters of insulin resistance and sex steroid levels Timepoint: at end of trial—

Countries

India

Contacts

Public ContactSmitha Bhat

Father Muller Medical College

doctorsmitha@fathermuller.in9845162167

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026